Metraipolis › archive › dc_f920d8325cfa

Qili Qiangxin ameliorates chronic heart failure: a randomized clinical trial of biomarkers, inflammation, and cardiac outcomes — Europe PMC PMID:41098835

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41098835
DOI
10.3389/fphar.2025.1605944
License (as archived)
solo-consultazione
Archived
2026-11-09T16:46:59.962Z
SHA-256 of the archived text
90568f1ffecb887331f5e261bfb40df98761eae92c0ce1299fe22df73eb98194
Stable URL of this page
https://metraipolis.com/documento/dc_f920d8325cfa

How to cite

Qili Qiangxin ameliorates chronic heart failure: a randomized clinical trial of biomarkers, inflammation, and cardiac outcomes — Europe PMC PMID:41098835 — Europe PMC (en), https://europepmc.org/article/MED/41098835 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_f920d8325cfa (Metraipolis archive dc_f920d8325cfa, sha256 90568f1ffecb887331f5e261bfb40df98761eae92c0ce1299fe22df73eb98194)
BibTeX
@misc{dcf920d8325cfa,
  title = {Qili Qiangxin ameliorates chronic heart failure: a randomized clinical trial of biomarkers, inflammation, and cardiac outcomes — Europe PMC PMID:41098835},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41098835},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_f920d8325cfa; sha256 90568f1ffecb887331f5e261bfb40df98761eae92c0ce1299fe22df73eb98194},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41098835. Agents can read the archived copy with the MCP tool read_document.